New blood-test studies suggest a way to detect CTE in living patients
Just the facts

New blood-test studies suggest a way to detect CTE in living patients

Summary

Two recent JAMA studies report blood biomarkers that correlate with chronic traumatic encephalopathy, offering a potential method for diagnosing the disease before death.

Two studies published this week in the Journal of the American Medical Association report that blood biomarkers may indicate the presence of chronic traumatic encephalopathy (CTE), a condition currently diagnosed only through post-mortem brain examination. The research from Washington University School of Medicine involved 229 participants, while a separate study by Boston University and Banner Health examined 21 former football players who had provided blood samples before death. In the Boston cohort, 18 were found to have CTE, with 16 classified as high-stage, and higher concentrations of the identified biomarker were observed in those cases.

Michael Alosco, co-director of clinical research at the CTE Center and co-author of the Boston study, described the findings as a potential "game changer" for diagnosing CTE in living athletes, though he noted the test currently appears most effective for advanced disease.

"I'm cautiously optimistic that we can really understand this finding and move it forward in the next five years or so," Alosco said.

The NFL, which has faced scrutiny over CTE prevalence among former players, issued a statement affirming its commitment to providing resources for physical and mental wellbeing. The league's CTE Center continues to explore multiple diagnostic approaches, including blood draws, cognitive testing and imaging techniques such as MRI and PET scans.

Keep reading — for free

Create a free account to follow the news. No card required.